Phytanic acid stimulates glucose uptake in a model of skeletal muscles, the primary porcine myotubes

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Che, Brita N ^a   Oksbjerg, Niels ^a   Hellgren, Lars I ^b   Nielsen, Jacob H ^c   Young, Jette F ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Excess glucose; Free fatty acids; Glucose uptake; Glycogen synthesis; Insulin; Palmitic acid; Phytanic acid; Primary porcine myotubes; Viability

Indexed keywords

INSULIN; PHYTANIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; MYOTUBE; NONHUMAN; SATELLITE CELL; SKELETAL MUSCLE; SWINE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; CELL SURVIVAL; DEOXYGLUCOSE; FATTY ACIDS; FEMALE; GLYCOGEN; INSULIN; MODELS, BIOLOGICAL; MUSCLE FIBERS, SKELETAL; PHYTANIC ACID; PRIMARY CELL CULTURE; SATELLITE CELLS, SKELETAL MUSCLE; SWINE; TRITIUM;

SUS;

EID: 84873492691     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-14     Document Type: Article

References (47)

1. Diet, nutrition and the prevention of type 2 diabetes. Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, Tuomilehto J, Lindstrom J, Louheranta A, Public Health Nutr 2004 7 147 165 14972058 (Pubitemid 38294515)
2. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study. Warensjo E, Jansson JH, Berglund L, Boman K, Ahren B, Weinehall L, Lindahl B, Hallmans G, Vessby B, Brit J Nutr 2004 91 635 642 10.1079/BJN20041080 15035691 (Pubitemid 38584788)
3. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Elwood PC, Pickering JE, Givens DI, Gallacher JE, Lipids 2010 45 925 939 10.1007/s11745-010-3412-5 20397059
4. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu BF, Engberik FM, Willett WC, Johanna GM, Am J Clin Nutr 2011 93 158 178 10.3945/ajcn.2010.29866 21068345
5. Intake of dairy fat and dairy products, and risk of myocardial infarction: a case-control study. Biong AS, Rebnord HM, Fimreite RL, Trygg KU, Ringstad J, Thelle DS, Pedersen JI, Int J Food Sci Nutr 2008 59 155 165 10.1080/09637480701532521 17886080 (Pubitemid 351338339)
6. Stroke and plasma markers of milk fat intake-a prospective nested case-control study. Warensjö E, Smedman A, Stegmayr B, Hallmans G, Weinehall L, Essby B, Johasson I, J Nutr 2009 8 21 10.1186/1475-2891-8-21
7. Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study. Warensjö E, Jansson J-H, Cederholm T, Boman K, Eliasson M, Hallmans G, Johansson I, Sjögren P, Am J Clin Nutr 2010 92 194 202 10.3945/ajcn.2009.29054 20484449
8. Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. Wolk A, Furuheim M, Vessby B, J Nutr 2001 131 828 833 11238766 (Pubitemid 32199152)
9. Conjugated Dienoic Linoleate: a polyunsaturated fatty acid with unique chemoprotective properties. Belury MA, Nutr Rev 1995 53 83 89 7624062
10. Milk fat in human nutrition. Parodi PW, Aust J Dairy Technol 2004 59 3 59 (Pubitemid 38604187)
11. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPAR alpha) in sterol carrier protein 2- sterol carrier protein x-deficient mice. Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U, J Biol Chem 1999 274 2766 2772 10.1074/jbc.274.5.2766 9915808 (Pubitemid 29075357)
12. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Kitareewan S, Burka LT, Tomer KB, Parker CE, Deterding LJ, Stevens RD, Forman BM, Mais DE, Heyman RA, McMorris T, Weinberger C, Mol Biol Cell 1996 7 1153 1166 8856661 (Pubitemid 26260734)
13. Phytanic acid is a retinoid X receptor ligand. Lemotte PK, Keidel S, Apfel CM, Eur J Biochem 1996 236 328 333 10.1111/j.1432-1033.1996.00328.x 8617282 (Pubitemid 26074886)
14. Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives. Grimaldi PA, Cell Mol Life Sci 2007 64 2459 2464 10.1007/s00018-007-7278-5 17876521 (Pubitemid 350035619)
15. Phytanic acid, a natural peroxisome proliferator-activated receptor agonist, regulates glucose metabolism in rat primary hepatocytes. Heim M, Johnson J, Boess F, Bendik I, Weber P, Hunziker W, Fluhmann B, FASEB J 2002 16 718 720 11923221
16. Phytanic acid-an overlooked bioactive fatty acid in dairy fat? Hellgren LI, Ann Ny Acad Sci 2010 1190 42 49 10.1111/j.1749-6632.2009.05254.x 20388135
17. Diet and Refsums disease-the determination of phytanic acid and Phytol in certain foods and the application of this knowledge to the choice of suitable convenience foods for patients with Refsums disease. Brown PJ, Mei G, Gibberd FB, Burston D, Mayne PD, Mcclinchy JE, Sidey M, J Hum Nutr Diet 1993 6 295 305 10.1111/j.1365-277X.1993.tb00375.x (Pubitemid 23250246)
18. Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders. Al-Dirbashi OY, Santa T, Rashed MS, Al-Hassnan Z, Shimozawa N, Chedrawi A, Jacob M, Al-Mokhadab M, J Lipid Res 2008 49 1855 1862 10.1194/jlr.D800019-JLR200 18441019
19. Phytanic acid: measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acids. Allen NE, Grace PB, Ginn A, Travis RC, Roddam AW, Appleby PN, Key T, Brit J Nutr 2008 99 653 659 17868488 (Pubitemid 351223434)
20. Regulation of glucose transporters by insulin and extracelluar glucose in C2C12 myotubes. Nedachi T, Kanzaki M, Am J Physiol-Endoc M 2006 291 817 E828 10.1152/ajpcell.00198.2006 (Pubitemid 44773672)
21. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: Decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Cooksey RC, Hebert J, Zhu JH, Wofford P, Garvey WT, McClain DA, Endocrinology 1999 140 1151 1157 10.1210/en.140.3.1151 10067838 (Pubitemid 29104215)
22. Overexpression of muscle lipoprotein lipase and insulin sensitivity. Pulawa LK, Eckel RH, Curr Opin Clin Nutr Metab Care 2002 5 569 574 10.1097/00075197-200209000-00017 12172482 (Pubitemid 40684654)
23. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferater-activated receptor alpha. Zomer AWM, van der Burg B, Jansen GA, Wanders RJA, Poll-The B, van der Saag PT, J Lipid Res 2000 41 1801 1807 11060349
24. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. He WM, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM, P Natl Acad Sci USA 2003 100 15712 15717 10.1073/pnas.2536828100 (Pubitemid 38021055)
25. PPAR-gamma expression modulates insulin sensitivity in C2C12 skeletal muscle cells. Verma NK, Singh J, Dey CS, Brit J Pharmacol 2004 143 1006 1013 10.1038/sj.bjp.0706002 (Pubitemid 40065501)
26. Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3 T3-L1 adipocytes. Liao W, Nguyen MTA, Yoshizaki T, Favelyukis S, Patsouris D, Imamura T, Verma IM, Olefsky JM, Am J Physiol-Endoc M 2007 293 219 E227
27. Regulation of muscle fiber type and running endurance by PPAR delta. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM, Plos Biol 2004 2 1532 1539
28. The chlorophyll metabolite phytanic acid is a natural rexinoid-Potential for treatment and prevention of diabetes. McCarty MF, Med Hypotheses 2001 56 217 219 10.1054/mehy.2000.1153 11425290 (Pubitemid 32202630)
29. The swine as a model for studying exercise-induced changes in lipid metabolism. Carey GB, Med Sci Sport Exer 1997 29 1437 1443 10.1097/00005768- 199711000-00008 (Pubitemid 27483987)
30. Establishment and conditions for growth and differentiation of a myoblast cell line derived from the semimembranosus muscle of newborn piglets. Mau M, Oksbjerg N, Rehfeldt C, In Vitro Cell Dev- An 2008 44 1 5
31. Fatty acids as modulators of the cellular production of reactive oxygen species. Schönfeld P, Wojtczak L, Free Radical Bio Med 2008 45 231 241 10.1016/j.freeradbiomed.2008.04.029
32. Comment concerning the article: 'Phytanic acid impairs mitochondrial respiration through protonophoric action' by Komen et al.: Branched chain phytanic acid inhibits the activity of the mitochondrial respiratory chain. Schönfeld P, Reiser G, Cell Mol Life Sci 2008 65 2266 2269 10.1007/s00018-008-8117-z 18581054
33. Effect of dairy fat on plasma phytanic acid in healthy volunteers-A randomized controlled study. Werner LB, Hellgren LI, Raff M, Jensen SK, Petersen RA, Drachmann T, Tholstrup T, Lipid Health Dis 2011 10 95 10.1186/1476-511X-10- 95
34. 2-Deoxyglucose; a metabolic block for glucose. Wickan DR, Morita TN, Proc Soc Exp Biol Med 1955 89 579 582 13254831
35. Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes. Mueckler M, Diabetes 1990 39 6 11 10.2337/diabetes.39.1.6 2210061 (Pubitemid 20022878)
36. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Al-Khalili L, Chibalin AV, Kannisto K, Zhang BB, Permert J, Holman GD, Ehrenborg E, Ding VDH, Zierath JR, Krook A, Cell Mol Life Sci 2003 60 991 998 12827286 (Pubitemid 36735127)
37. Cytochalasin B: inhibition of glucose and glucosamine transport. Ebstensen RD, Plagemann PG, P Natl Acad Sci USA 1972 69 1430 1434 10.1073/pnas.69.6.1430
38. Cytochalasin B binding sites and glucose transport carrier in human erythrocytes ghosts. Chan YJ, Amrit LR, J Biol Chem 1977 252 5456 5463 885863
39. Insight into the "odd" hexose transporters GLUT3, GLUT5, and GLUT7. Schürmann A, Am J Physiol-Endoc M 2008 295 225 E226
40. Glucose-transport in human skeletal-muscle cells in culture-stimulation by insulin and metformin. Sarabia V, Lam L, Burdett E, Leiter LA, Klip A, J Clin Invest 1992 90 1386 1395 10.1172/JCI116005 1401073
41. Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: Role of p38 MAPK. Archuleta TL, Lemieux AM, Saengsirisuwan V, Teachey MK, Lindborg KA, Kim JS, Henriksen EJ, Free Radical Bio Med 2009 47 1486 1493 10.1016/j.freeradbiomed.2009.08.014
42. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of glut4. Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, Zong H, Dong J, Kahn CR, Kahn BB, Shulman GI, J Clin Invest 2001 108 153 160 11435467 (Pubitemid 32634932)
43. Mechanisms of disease-glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. Shepherd PR, Kahn BB, New Engl J Med 1999 341 248 257 10.1056/NEJM199907223410406 10413738 (Pubitemid 29334524)
44. Temporal expression of growth factor genes of primary porcine satellite cells during myogenesis. Theil PK, Sorensen IL, Nissen PM, Oksbjerg N, J Anim Sci 2006 77 330 337 10.1111/j.1740-0929.2006.00356.x (Pubitemid 43807327)
45. Platelet-derived growth factor induces apoptosis in vascular smooth muscle cells: roles of the Bcl-2 family. Okura T, Igase M, Kitami Y, Fukuoka T, Maguchi M, Kohara K, Hiwada K, BBA-Mol Cell Res 1998 1403 245 253 (Pubitemid 28451565)
46. Measurement of protein using bincinchoninic acid. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC, Anal Biochem 1985 150 76 85 10.1016/0003-2697(85)90442-7 3843705 (Pubitemid 16258399)
47. Protein-kinase-C is Not required for insulin stimulation of hexose uptake in muscle-cells in culture. Klip A, Ramlal T, Biochem J 1987 242 131 136 3297042 (Pubitemid 17015455)